Exagen Inc. (XGN) Tops Q1 EPS by 24c

Exagen Inc. (NASDAQ: XGN) reported Q1 EPS of ($0.44), $0.24 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.4 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings